102 related articles for article (PubMed ID: 26977569)
1. [Use of Myrtol standardized in the treatment of children with acute rhinosinusitis].
Karpova EP; Tulupov DA; Emel'yanova MP
Vestn Otorinolaringol; 2016; 81(1):47-50. PubMed ID: 26977569
[TBL] [Abstract][Full Text] [Related]
2. The effect of myrtol standardized on human nasal ciliary beat frequency and mucociliary transport time.
Han D; Wang N; Zhang L
Am J Rhinol Allergy; 2009; 23(6):610-4. PubMed ID: 19822035
[TBL] [Abstract][Full Text] [Related]
3. [Myrtol standardized in treatment of acute rhinosinusitis].
Gromakov VA
Vestn Otorinolaringol; 2012; (1):57-8. PubMed ID: 22678643
[No Abstract] [Full Text] [Related]
4. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
[TBL] [Abstract][Full Text] [Related]
5. Multicenter, randomized, open-label, comparative study of the effectiveness of nasal spray Aqua Maris Extra Strong as a symptomatic therapy in the technology of delayed antibiotic prescription in the treatment of acute rhinosinusitis in children aged 6-11 years.
Popovych VI; Koshel IV; Piletska LI; Orlovska RM
Am J Otolaryngol; 2024; 45(2):103644. PubMed ID: 36207156
[TBL] [Abstract][Full Text] [Related]
6. An open-label, multicentre, randomized comparative study of efficacy, safety and tolerability of the 5 plant - extract BNO 1012 in the Delayed Antibiotic Prescription Method in children, aged 6 to 11 years with acute viral and post-viral rhinosinusitis.
Popovych VI; Beketova HV; Koshel IV; Tsodikova OA; Kriuchko TA; Abaturov AE; Vakulenko LI; Gavrylenko IV
Am J Otolaryngol; 2020; 41(5):102564. PubMed ID: 32593046
[TBL] [Abstract][Full Text] [Related]
7. Pediatric acute and chronic rhinosinusitis: comparison of clinical characteristics and outcome of treatment.
Poachanukoon O; Nanthapisal S; Chaumrattanakul U
Asian Pac J Allergy Immunol; 2012 Jun; 30(2):146-51. PubMed ID: 22830294
[TBL] [Abstract][Full Text] [Related]
8. [Effects of standardized Myrtol in therapy of acute sinusitis--results of a double-blind, randomized multicenter study compared with placebo].
Federspil P; Wulkow R; Zimmermann T
Laryngorhinootologie; 1997 Jan; 76(1):23-7. PubMed ID: 9156505
[TBL] [Abstract][Full Text] [Related]
9. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
Poachanukoon O; Kitcharoensakkul M
Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
[TBL] [Abstract][Full Text] [Related]
11. [Myrtol standardized in the treatment of acute and chronic respiratory infections in children. A multicenter post-marketing surveillance study].
Sengespeik HC; Zimmermann T; Peiske C; de Mey C
Arzneimittelforschung; 1998 Oct; 48(10):990-4. PubMed ID: 9825116
[TBL] [Abstract][Full Text] [Related]
12. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo.
Inanli S; Oztürk O; Korkmaz M; Tutkun A; Batman C
Laryngoscope; 2002 Feb; 112(2):320-5. PubMed ID: 11889391
[TBL] [Abstract][Full Text] [Related]
13. [Acute rhinosinusitis: diagnostics and treatment].
Lazarevich IA; Kozlov VS
Vestn Otorinolaringol; 2013; (5):88-92. PubMed ID: 24600714
[TBL] [Abstract][Full Text] [Related]
14. Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis.
Meltzer EO; Gates D; Bachert C
Ann Allergy Asthma Immunol; 2012 Apr; 108(4):275-9. PubMed ID: 22469449
[TBL] [Abstract][Full Text] [Related]
15. Comparison of amoxicillin + clavulanate with or without intranasal fluticasone for the treatment of uncomplicated acute rhinosinusitis in children.
Wan KS; Wu WF; Chen TC; Wu CS; Hung CW; Chang YS
Minerva Pediatr; 2015 Dec; 67(6):489-94. PubMed ID: 26530491
[TBL] [Abstract][Full Text] [Related]
16. A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis.
Gillissen A; Wittig T; Ehmen M; Krezdorn HG; de Mey C
Drug Res (Stuttg); 2013 Jan; 63(1):19-27. PubMed ID: 23447044
[TBL] [Abstract][Full Text] [Related]
17. Observational study on the performance of the Narhinel method (nasal aspirator and physiological saline solution) versus physiological saline solution in the prevention of recurrences of viral rhinitis and associated complications of the upper respiratory tract infections (URTI), with a special focus on acute rhinosinusitis and acute otitis of the middle ear.
Montanari G; Ceschin F; Masotti S; Bravi F; Chinea B; Quartarone G
Minerva Pediatr; 2010 Feb; 62(1):9-16, 17-21. PubMed ID: 20212394
[TBL] [Abstract][Full Text] [Related]
18. [The role of mucolytic therapy in the treatment of sinobronchial syndrome].
Zaĭtseva OV
Vestn Otorinolaringol; 2012; (2):63-5. PubMed ID: 22810642
[TBL] [Abstract][Full Text] [Related]
19. [Oxytetracycline + myrtol standardized in sinusitis and bronchitis. General practice test passed with "very good"].
MMW Fortschr Med; 2006 Jan; 148(1-2):49. PubMed ID: 16610419
[No Abstract] [Full Text] [Related]
20. Myrtol standardized affects mucociliary clearance.
Li YY; Liu J; Li CW; Subramaniam S; Chao SS; Yu FG; Cohen NA; Li S; Wang Y
Int Forum Allergy Rhinol; 2017 Mar; 7(3):304-311. PubMed ID: 27888644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
